Comparison of Carbon Dioxide and Saline Flush to Saline Flush in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03998631|
Recruitment Status : Recruiting
First Posted : June 26, 2019
Last Update Posted : September 23, 2020
|Condition or disease||Intervention/treatment||Phase|
|Thoracic Aortic Aneurysm Aortic Stenosis Symptomatic Stroke, Complication||Procedure: Carbon Dioxide and Saline Flush Procedure: Standard Saline Flush||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Comparison of Carbon Dioxide Flush and Saline Flush to Saline Flush Alone in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia|
|Actual Study Start Date :||July 20, 2019|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||March 31, 2021|
Placebo Comparator: Saline Flush
This is the control arm. The TEVAR or TAVI device will be flushed with at least 60mL of standard saline to reduce bubbles in the reservoir prior to deployment. This is the standard of care.
Procedure: Standard Saline Flush
Standard of care flushing of the TEVAR or TAVI device with normal saline.
Experimental: Carbon Dioxide and Saline Flush
Carbon dioxide flush of the TEVAR or TAVI device followed by saline flush.
Procedure: Carbon Dioxide and Saline Flush
The TEVAR or TAVI device will be flushed with approximately 1.2L of medical grade carbon dioxide using a 60mL syringe and connecting tubing. The reservoir will then be flushed with at least 60mL of standard saline prior to deployment to minimize bubbles in the saline.
- Complications [ Time Frame: 30 days ]Infection, bleeding, stroke, pseudoaneurysm formation, etc.
- All cause mortality [ Time Frame: 30 days ]Post procedural death.
- Stroke [ Time Frame: 7 days ]Physical examination and magnetic resonance imaging (MRI) brain.
- Silent Infarction [ Time Frame: 7 days ]MRI brain.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03998631
|Contact: Kong Teng Tan, MD, FRCPC||416-340-4800 ext firstname.lastname@example.org|
|University Health Network||Recruiting|
|Toronto, Ontario, Canada, M5G 2C4|
|Contact: Kong Teng Tan, MD 416 340-3111|
|Principal Investigator: Kong Teng Tan, MD|
|Principal Investigator:||Kong Teng Tan, MD, FRCPC||University Health Network, Toronto|